Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms

Nature Genetics

Volumn 45, Issue 10, 2013, Pages 1232-1237

  Kon, Ayana ^a   Shih, Lee Yung ^b   Minamino, Masashi ^c   Sanada, Masashi ^a,d   Shiraishi, Yuichi ^c   Nagata, Yasunobu ^a   Yoshida, Kenichi ^a   Okuno, Yusuke ^a   Bando, Masashige ^c   Nakato, Ryuichiro ^c   Ishikawa, Shumpei ^c,e   Sato Otsubo, Aiko ^a   Nagae, Genta ^f   Nishimoto, Aiko ^c   Haferlach, Claudia ^g   Nowak, Daniel ^h   Sato, Yusuke ^a   Alpermann, Tamara ^g   Nagasaki, Masao ⁱ   Shimamura, Teppei ^c   Tanaka, Hiroko ^j   Chiba, Kenichi ^c   Yamamoto, Ryo ^c,k   Yamaguchi, Tomoyuki ^j   Otsu, Makoto ^l   Obara, Naoshi ^l   Sakata Yanagimoto, Mamiko ^m   Nakamaki, Tsuyoshi ⁿ   Ishiyama, Ken ^h   Nolte, Florian ^h   Hofmann, Wolf Karsten ⁿ   Miyawaki, Shuichi ^l   Chiba, Shigeru ^m   Mori, Hiraku ^c,k   Nakauchi, Hiromitsu ^o,p   Koeffler, H Phillip ^f   Aburatani, Hiroyuki ^g   Haferlach, Torsten ^c   Shirahige, Katsuhiko ^c,j   Miyano, Satoru ^a,d   Ogawa, Seishi ^a,d   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

^g MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ TOHOKU UNIVERSITY   (Japan)

^j THE UNIVERSITY OF TOKYO   (Japan)

^k JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^l UNIVERSITY OF TSUKUBA   (Japan)

^m SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^o CEDARS SINAI MEDICAL CENTER   (United States)

^p NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COHESIN; RAD21 PROTEIN; SMC1A PROTEIN; SMC3 PROTEIN; STAG2 PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BINDING SITE; CANCER GROWTH; CHROMATIN; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; WILD TYPE;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MUTATION;

EID: 84885021313     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2731     Document Type: Article

References (50)

1. Bejar, R., Levine, R. & Ebert, B.L. Unraveling the molecular pathophysiology of myelodysplastic syndromes. J. Clin. Oncol. 29, 504-515 (2011).
2. Marcucci, G., Haferlach, T. & Dohner, H. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications. J. Clin. Oncol. 29, 475-486 (2011).
3. Yoshida, K., et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 478, 64-69 (2011).
4. Gruber, S., Haering, C.H. & Nasmyth, K. Chromosomal cohesin forms a ring. Cell 112, 765-777 (2003).
5. Nasmyth, K. & Haering, C.H. Cohesin: its roles and mechanisms. Annu. Rev. Genet. 43, 525-558 (2009).
6. Ström, L., et al. Postreplicative formation of cohesion is required for repair and induced by a single DNA break. Science 317, 242-245 (2007).
7. Watrin, E. & Peters, J.M. The cohesin complex is required for the DNA damage-induced G2/M checkpoint in mammalian cells. EMBO J. 28, 2625-2635 (2009).
8. Dorsett, D. Cohesin, gene expression and development: lessons from Drosophila. Chromosome Res. 17, 185-200 (2009).
9. Dorsett, D., et al. Effects of sister chromatid cohesion proteins on cut gene expression during wing development in Drosophila. Development 132, 4743-4753 (2005).
10. Horsfield, J.A., et al. Cohesin-dependent regulation of Runx genes. Development 134, 2639-2649 (2007).
11. Parelho, V., et al. Cohesins functionally associate with CTCF on mammalian chromosome arms. Cell 132, 422-433 (2008).
12. Wendt, K.S., et al. Cohesin mediates transcriptional insulation by CCCTC-binding factor. Nature 451, 796-801 (2008).
13. Bose, T. & Gerton, J.L. Cohesinopathies, gene expression, and chromatin organization. J. Cell Biol. 189, 201-210 (2010).
14. Deardorff, M.A., et al. HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle. Nature 489, 313-317 (2012).
15. Deardorff, M.A., et al. RAD21 mutations cause a human cohesinopathy. Am. J. Hum. Genet. 90, 1014-1027 (2012).
16. Solomon, D.A., et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333, 1039-1043 (2011).
17. Beckouët, F., et al. An Smc3 acetylation cycle is essential for establishment of sister chromatid cohesion. Mol. Cell 39, 689-699 (2010).
18. Liu, J., et al. Transcriptional dysregulation in NIPBL and cohesin mutant human cells. PLoS Biol. 7, e1000119 (2009).
19. Liu, J., et al. Genome-wide DNA methylation analysis in cohesin mutant human cell lines. Nucleic Acids Res. 38, 5657-5671 (2010).
20. Schaaf, C.A., et al. Regulation of the Drosophila enhancer of split and invected-engrailed gene complexes by sister chromatid cohesion proteins. PLoS ONE 4, e6202 (2009).
21. Ding, L., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481, 506-510 (2012).
22. Walter, M.J., et al. Clonal architecture of secondary acute myeloid leukemia. N. Engl. J. Med. 366, 1090-1098 (2012).
23. Welch, J.S., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264-278 (2012).
24. The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059-2074 (2013).
25. Walter, M.J., et al. Clonal diversity of recurrently mutated genes in myelodysplastic syndromes. Leukemia 27, 12785-1282 (2013).
26. Barber, T.D., et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc. Natl. Acad. Sci. USA 105, 3443-3448 (2008).
27. Heidinger-Pauli, J.M., Mert, O., Davenport, C., Guacci, V. & Koshland, D. Systematic reduction of cohesin differentially affects chromosome segregation, condensation, and DNA repair. Curr. Biol. 20, 957-963 (2010).
28. Hadjur, S., et al. Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature 460, 410-413 (2009).
29. Chan, D.A. & Giaccia, A.J. Harnessing synthetic lethal interactions in anticancer drug discovery. Nat. Rev. Drug Discov. 10, 351-364 (2011).
30. Sato, Y., et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. doi:10.1038/ng.2699 (24 June 2013).
31. Kent, W.J. BLAT-The BLAST-like alignment tool. Genome Res. 12, 656-664 (2002).
32. Li, H., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
33. Kumar, P., Henikoff, S. & Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009).
34. Adzhubei, I.A., et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
35. Schwarz, J.M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods 7, 575-576 (2010).
36. Ronaghi, M. Pyrosequencing sheds light on DNA sequencing. Genome Res. 11, 3-11 (2001).
37. Shih, L.Y., et al. Emerging kinetics of BCR-ABL1 mutations and their effect on disease outcomes in chronic myeloid leukemia patients with imatinib failure. Leuk. Res. 37, 43-49 (2013).
38. Qin, J., Jones, R.C. & Ramakrishnan, R. Studying copy number variations using a nanofluidic platform. Nucleic Acids Res. 36, e116 (2008).
39. Dube, S., Qin, J. & Ramakrishnan, R. Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS ONE 3, e2876 (2008).
40. Totoki, Y., et al. High-resolution characterization of a hepatocellular carcinoma genome. Nat. Genet. 43, 464-469 (2011).
41. Nannya, Y., et al. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res. 65, 6071-6079 (2005).
42. Yamamoto, G., et al. Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am. J. Hum. Genet. 81, 114-126 (2007).
43. Hosoya, N., et al. Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization. Genes Chromosom. Cancer 45, 482-494 (2006).
44. Sanada, M., et al. Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms. Nature 460, 904-908 (2009).
45. Nagae, G., et al. Tissue-specific demethylation in CpG-poor promoters during cellular differentiation. Hum. Mol. Genet. 20, 2710-2721 (2011).
46. Nabekura, T., Otsu, M., Nagasawa, T., Nakauchi, H. & Onodera, M. Potent vaccine therapy with dendritic cells genetically modified by the gene-silencing resistant retroviral vector GCDNsap. Mol. Ther. 13, 301-309 (2006).
47. Agarwal, S., et al. Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proc. Natl. Acad. Sci. USA 103, 15933-15938 (2006).
48. Li, C. & Wong, W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98, 31-36 (2001).
49. Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5, 621-628 (2008).
50. Pruitt, K.D., Tatusova, T., Brown, G.R. & Maglott, D.R. NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res. 40, D130 D135 (2012).